Sun Pharma’s $75 Million Deal Gets Nod in Drug Antitrust Case

Sun Pharmaceutical Industries Inc. exited antitrust litigation over an alleged industrywide scheme to fix generic drug prices after a federal judge approved a settlement worth $75 million to $95 million.

Judge Cynthia M. Rufe signed off on the agreement, which resolves some of the claims facing Sun as part of a sprawling dispute involving hundreds of drugs, dozens of pharmaceutical companies, and scores of plaintiffs, including large health-care companies and nearly every state government.

Rufe has by turns narrowed the case—centralized in the US District Court for the Eastern District of Pennsylvania—and rebuffed requests to scale it back. She recently ...